Improving first-line decision-making and multidisciplinary approach in advanced urothelial carcinoma
Disponibilidad: Hay plazas
- Overview
- Learning Objectives
- Target Audience
- Learning Methodology
- Programme
- Faculty
- Accreditation
- Scientific Independence
Overview
The rapid evolution of therapeutic options for urothelial carcinoma makes continuous education based on the latest scientific evidence and multidisciplinary clinical expertise more essential than ever.
The management of locally advanced/metastatic urothelial carcinoma (la/mUC) and muscle-invasive bladder cancer (MIBC) has undergone a profound transformation in recent years. The introduction of novel therapeutic strategies together with the continuous evolution of scientific evidence has significantly increased the complexity of clinical decision-making.
This educational programme aims to provide a practical and evidence-based update on the latest advances, supporting healthcare professionals in integrating current evidence into everyday clinical practice through a multidisciplinary, patient-centred approach aligned with contemporary clinical recommendations.
Through virtual Journal Clubs, online learning modules and discussions of real-world clinical cases, the programme promotes critical appraisal of the scientific literature and its direct application to clinical decision-making in daily practice.
Learning Objectives
This programme has been designed to strengthen clinical decision-making by enhancing knowledge, fostering critical appraisal of scientific evidence and encouraging multidisciplinary collaboration among healthcare professionals.
To enhance healthcare professionals’ knowledge, clinical competence and confidence in the management of urothelial carcinoma by facilitating the integration of the latest scientific evidence into routine clinical practice.
Target Audience
This programme is designed for healthcare professionals involved in the treatment and follow-up of patients with urothelial carcinoma, promoting a multidisciplinary approach and evidence-based clinical practice.
This programme is also intended for healthcare professionals from other medical and nursing specialties who wish to update their knowledge of advanced urothelial carcinoma management, develop their skills in the critical appraisal of scientific evidence, and strengthen its application in clinical practice.
Learning Methodology
The programme combines self-paced online learning modules with recordings of expert-led educational sessions delivered in Spanish and provided with English subtitles.
All online modules are available throughout the programme, allowing participants to progress at their own pace. The recordings of the educational sessions are provided in their original Spanish language with English subtitles to facilitate access for an international audience.
Programme
The programme is organised into two complementary components: three live virtual Journal Clubs and three on-demand online learning modules.
Three live online sessions will be delivered on a monthly basis, focusing on the critical appraisal of recent scientific literature and its application to clinical practice.
Schedule: September, October and November 2026.
Duration: 90 minutes per session.
To complement the live sessions, the programme includes three on-demand online learning modules aligned with the webinar content. Each module has an estimated duration of one hour and includes expert-led video lectures, summaries of key concepts, practical infographics and self-assessment activities.
Faculty
Faculty
The programme is delivered by a multidisciplinary faculty with extensive expertise in medical education, medical oncology and genitourinary malignancies.
Senior Researcher at the Catalan Institute of Oncology (ICO) and Associate Professor at UVic-UCC. She has extensive experience in the design, coordination and evaluation of educational programmes for healthcare professionals.
Specialist in genitourinary malignancies, with a particular interest in urothelial carcinoma, immunotherapy, precision oncology and clinical research.
Specialist in genitourinary malignancies, with a focus on optimising systemic therapies and promoting evidence-based clinical practice.
Specialist in urothelial carcinoma, clinical research, personalised medicine and evidence-based therapeutic strategies.
Accreditation
This educational activity has been submitted for accreditation within the Spanish Continuing Professional Development (CPD) accreditation system for healthcare professionals.
Accreditation has been requested from the Catalan Council for Continuing Education of the Health Professions (CCFCPS) / Continuing Education Commission of the Spanish National Health System (CFC-SNS).
This is a Spanish national accreditation and does not correspond to European CME/CPD accreditation.
The awarded credits are intended exclusively for licensed healthcare professionals in clinical practice. Healthcare professionals undertaking specialist training (medical residents) are not eligible for accreditation.
Scientific Independence
This educational activity is developed with full scientific, academic and editorial independence.
This educational programme is supported by an Independent Medical Education (IME) Grant from Astellas. The provision of this educational grant has not influenced, and will not influence, the programme design, content development, faculty selection, educational methodology, participant assessment or dissemination of the activity.
Scientific independence
The programme is planned and delivered with complete scientific, academic and editorial independence, in accordance with the principles governing independent medical education.
Más cursos que podrían interesarte
Conoce nuestra formación organizada por áreas formativas.
Haz clic en cada una de ellas para visualizar los cursos.


